⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GANX News
Gain Therapeutics, Inc. Common Stock
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
globenewswire.com
GANX
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
globenewswire.com
GANX